The 21st Applied Pharmaceutical Analysis (APA) Conference will take place September 14–16, 2026, at Sanofi in Cambridge, Massachusetts. Organized by The Boston Society, APA is a scientific forum dedicated to advancing analytical science in support of drug discovery and development.
The conference brings together scientists from pharmaceutical and biotechnology companies, CROs, academia, and regulatory agencies to exchange knowledge, explore emerging technologies, and address current challenges in pharmaceutical analysis. The 2026 program will feature focused workshops covering Regulated Bioanalysis, Discovery Bioanalysis & New Technologies, and Mechanistic ADME.
21st Applied Pharmaceutical Analysis (APA) Conference
📅 September 14–16, 2026
📍 Sanofi | Cambridge, MA, USA
Connect with Eurofins Clinical Trial Solutions at APA 2026 to discuss your upcoming programs and bioanalytical and biomarker testing needs.
Our scientific teams provide specialized expertise across:
By combining scientific expertise, regulatory experience, and fit-for-purpose analytical strategies, Eurofins Clinical Trial Solutions supports sponsors across complex drug development programs and emerging therapeutic modalities.
Rapid-Fire Poster Presentation
Mark Wissel, PhD, Director, R&D, will participate in the Rapid-Fire Poster Presentations during the Discovery Bioanalysis & New Technologies Workshop.
Supporting Shedding, Biodistribution and Infection Identification Bioanalysis: The Optimization of Methods for Urine in Bioanalytical qPCR
📅 Tuesday, September 15, 2026
⏰ 12:20–12:45 PM – Rapid-Fire Poster Presentations
📍 Discovery Bioanalysis & New Technologies Workshop
The presentation will highlight the optimization of bioanalytical qPCR methods for urine to support shedding, biodistribution, and infection identification bioanalysis.
Connect with our experts onsite throughout the conference:
Attending APA 2026? Schedule time with Eurofins Clinical Trial Solutions to discuss your upcoming programs, bioanalytical challenges, and testing needs.